Topotecan for Relapsed Small-cell Lung Cancer: Systematic Review and Meta-Analysis of 1347 Patients

Topotecan is the most reliable chemotherapy regimen for relapsed small-cell lung carcinoma (SCLC). The efficacy and adverse effects of topotecan as reported by previous studies varied greatly. The inclusion criterion was a prospective study that was able to provide data for 6-month over-all survival...

Szczegółowa specyfikacja

Zapisane w:
Opis bibliograficzny
Wydane w:Sci Rep
Główni autorzy: Horita, Nobuyuki, Yamamoto, Masaki, Sato, Takashi, Tsukahara, Toshinori, Nagakura, Hideyuki, Tashiro, Ken, Shibata, Yuji, Watanabe, Hiroki, Nagai, Kenjiro, Inoue, Miyo, Nakashima, Kentaro, Ushio, Ryota, Shinkai, Masaharu, Kudo, Makoto, Kaneko, Takeshi
Format: Artigo
Język:Inglês
Wydane: Nature Publishing Group 2015
Hasła przedmiotowe:
Article
Dostęp online:https://ncbi.nlm.nih.gov/pmc/articles/PMC4614251/
https://ncbi.nlm.nih.gov/pubmed/26486755
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/srep15437
Etykiety: Dodaj etykietę
Nie ma etykietki, Dołącz pierwszą etykiete!

Podobne zapisy